Gastrointestinal effects GLP-1 medications commonly cause nausea, bloating, constipation, and diarrhea
Container: Keep in the original, tightly sealed, airtight vial typically amber glass to minimise exposure to air and moisture
The KLOW stack combined: Using the protocol means administering two WADA-prohibited compounds (BPC-157, TB-500), one injectable-restricted compound (GHK-Cu), and one unlisted-but-unapproved compound (KPV) via subcutaneous injection
Side Effects Common side effects of Mounjaro include nausea, vomiting, diarrhea, decreased appetite, constipation, indigestion and abdominal pain
In other words, those with insurance who bear a share of the cost of the drug, based on list price
In a recent study, after 68 weeks, patients saw between 15-20% total body weight reduction